HealthTree Logo
search more_vert
close
person Sign In / Create Account
Fixed-Duration vs. Continuous-Duration CLL Medicines with Dr. Alvaro Alencar
Fixed-Duration vs. Continuous-Duration CLL Medicines with Dr. Alvaro Alencar image
Adult CLL Chapter
event Jun 18, 2024 / 01:00PM - 02:00PM EDT

Video Recording Coming Soon


Event Description

When faced with choosing a CLL treatment, which do you choose? Become a more informed patient by learning about the differences between fixed-duration and continuous-duration CLL therapies from Dr. Alvaro Alencar! If you are unable to attend the event but have a question for Dr. Alencar, please email cll@healthtree.org. 

Schedule & Agenda

The panelist Megan Heaps
Introduction
1:00 PM
Megan Heaps

Megan introduces the agenda of the event and featured speaker Dr. Alvaro Alencar. 

The panelist Alvaro Alencar, M.D.
Presentation
1:05 PM
Alvaro Alencar, M.D.

Dr. Alencar shares insight about the differences between fixed-duration and continuous-duration CLL medicines.

The panelist Audience
Questions and Answers
1:35 PM
Audience

Type your questions in the chat, and Dr. Alencar will answer them!

Speakers & Moderators

The panelist Alvaro Alencar, M.D.
Alvaro Alencar, M.D.
Miami, Florida

Dr. Alencar is an Associate Professor of Clinical Medicine and the Chief Medical Officer at University of Miami Sylvester Comprehensive Cancer Center. He is a member of the lymphoma program at Sylvester and the lymphoma committee at the Alliance for Clinical Trials in Oncology. As the hematology section lead for the Sylvester’s Global Oncology Program, Dr. Alencar serves as an important bridge to the United States for Latin American hematologists being a constant presence in meetings, lectures, as well as tumor board and second opinions. These collaborations have led to a large multinational study evaluating the impact of genetic changes and ancestry on outcomes of Hispanic patients with blood disorders.

Read Bio
The panelist Megan Heaps
Megan Heaps

Megan joined HealthTree as the Program Manager for CLL in 2022. She is the daughter of a blood cancer patient and has found a passion for helping support patients and caregivers to advance research for their cure and improve their quality of life.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Chronic Lymphocytic Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Chronic Lymphocytic Leukemia Newsletter" for Chronic Lymphocytic Leukemia news, life with Chronic Lymphocytic Leukemia stories, Chronic Lymphocytic Leukemia clinical trials, Chronic Lymphocytic Leukemia 101 articles and events with Chronic Lymphocytic Leukemia experts.

Thanks to our HealthTree Community for Chronic Lymphocytic Leukemia Sponsors:

Abbvie
Genentech

Follow Us

facebook instagram youtube